{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:38:25Z","timestamp":1715787505470},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,13]]},"DOI":"10.1097\/qad.0b013e328335cead","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T06:34:01Z","timestamp":1267598041000},"page":"783-785","source":"Crossref","is-referenced-by-count":9,"title":["Epidemic Stevens\u2013Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy?"],"prefix":"10.1097","volume":"24","author":[{"given":"In\u00e9s","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Jensen-Fangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostinho","family":"Ndumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candida","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albino","family":"Nanadje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dlama N","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Rudolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wejse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zacarias J","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Sodemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex L","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20210130","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"R2-22-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00228-003-0613-3","article-title":"Incidence and risk factors for nevirapine-associated rash","volume":"59","author":"de Maat","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"R3-22-20210130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(98)24008-6","article-title":"Nevirapine-associated Stevens\u2013Johnson syndrome","volume":"351","author":"Warren","year":"1998","journal-title":"Lancet"},{"key":"R4-22-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R5-22-20210130","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00002030-200109280-00014","article-title":"Nevirapine and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"15","author":"Fagot","year":"2001","journal-title":"AIDS"},{"key":"R7-22-20210130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1468-1293.2007.00477.x","article-title":"Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women","volume":"8","author":"Phanuphak","year":"2007","journal-title":"HIV Med"},{"key":"R8-22-20210130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"R9-22-20210130","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/00126334-200412150-00005","article-title":"Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India","volume":"37","author":"Pujari","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-22-20210130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00002030-200501030-00014","article-title":"Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts","volume":"19","author":"Martin","year":"2005","journal-title":"AIDS"},{"key":"R11-22-20210130","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0149-2918(98)80105-7","article-title":"Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection","volume":"20","author":"Pollard","year":"1998","journal-title":"Clin Ther"},{"key":"R12-22-20210130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1086\/343046","article-title":"A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997\u20131999","volume":"35","author":"Bonnet","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R13-22-20210130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-200501280-00011","article-title":"Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs","volume":"19","author":"Ananworanich","year":"2005","journal-title":"AIDS"},{"key":"R14-22-20210130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00126334-200305010-00007","article-title":"Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1","volume":"33","author":"Montaner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-22-20210130","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/00002030-200207260-00020","article-title":"Female sex but not ethnicity is a strong predictor of nonnucleoside reverse transcriptase inhibitor-induced rash","volume":"16","author":"Mazhude","year":"2002","journal-title":"AIDS"},{"key":"R16-22-20210130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/317536","article-title":"Sex differences in nevirapine rash","volume":"32","author":"Bersoff-Matcha","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R17-22-20210130","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/00002030-200108170-00018","article-title":"Female sex and the use of antiallergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"R18-22-20210130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00126334-200104150-00009","article-title":"Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine","volume":"26","author":"Sabin","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-22-20210130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(05)79417-4","article-title":"Nevirapine and rashes","volume":"351","author":"Barner","year":"1998","journal-title":"Lancet"},{"key":"R20-22-20210130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1258\/095646207782212289","article-title":"Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells\/microL","volume":"18","author":"Manosuthi","year":"2007","journal-title":"Int J STD AIDS"},{"key":"R21-22-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157016208783571946","article-title":"Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings","volume":"6","author":"Kiertiburanakul","year":"2008","journal-title":"Curr HIV Res"},{"key":"R22-22-20210130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.aids.0000162334.12815.5b","article-title":"The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART","volume":"19","author":"van Leth","year":"2005","journal-title":"AIDS"},{"key":"R23-22-20210130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/QAD.0b013e32801199d9","article-title":"HLA-Cw8 primarily associated with hypersensitivity to nevirapine","volume":"21","author":"Gatanaga","year":"2007","journal-title":"AIDS"},{"key":"R24-22-20210130","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2165\/00002018-200528120-00003","article-title":"Sex differences in antiretroviral therapy-associated intolerance and adverse events","volume":"28","author":"Clark","year":"2005","journal-title":"Drug Saf"},{"key":"R25-22-20210130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/01.aids.0000238408.82947.09","article-title":"HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients","volume":"20","author":"Littera","year":"2006","journal-title":"AIDS"},{"key":"R26-22-20210130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/01.aids.0000171419.29905.93","article-title":"Nevirapine-induced Stevens\u2013Johnson syndrome in a mother and son","volume":"19","author":"Liechty","year":"2005","journal-title":"AIDS"},{"key":"R27-22-20210130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAD.0b013e3282f37812","article-title":"HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz","volume":"22","author":"Vitezica","year":"2008","journal-title":"AIDS"},{"key":"R28-22-20210130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/sti.2007.025353","article-title":"Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998\u20131999","volume":"83","author":"Mansson","year":"2007","journal-title":"Sex Transm Infect"},{"key":"R29-22-20210130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/QAD.0b013e328300a33d","article-title":"Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?","volume":"22","author":"da Silva","year":"2008","journal-title":"AIDS"},{"key":"R30-22-20210130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1473-3099(07)70262-1","article-title":"Is it safe to switch between efavirenz and nevirapine in the event of toxicity?","volume":"7","author":"Mehta","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R31-22-20210130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1468-1293.2006.00396.x","article-title":"Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash","volume":"7","author":"Manosuthi","year":"2006","journal-title":"HIV Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201003130-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:11:22Z","timestamp":1618038682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201003130-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,13]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328335cead","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,13]]}}}